U.S. Markets open in 43 hrs, 10 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 8,280.74 | -223.32 | -2.63% |
| NASDAQ | 1,796.52 | -49.20 | -2.67% |
| S&P 500 | 896.42 | -26.91 | -2.91% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 9.35 09:40 AM EDT | |
|---|---|---|
| Day High | 9.86 11:44 AM EDT |
|
| Range | 0.51 |
| Volume | 305,746 | |
|---|---|---|
| 30-Day Avg Vol | 348,000 |
|
| Difference | -12.14% |
| Market Cap | 471.63 M | |
|---|---|---|
| Mkt Cap Chg | -2.89 M |
| Shares Out | 48.17 M | |
|---|---|---|
| % Shrs Traded | 0.63% | |
| 1yr EPS Est | -0.773 |
| 52-Wk Low | 5.07 10/10/08 | |
|---|---|---|
| 52-Wk High | 12.64 4/9/09 |
|
| Range | 7.57 |
| Prev Close | 9.85 7/1/09 | |
|---|---|---|
| Today's Open | 9.76 | |
| Change | -0.91% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 4.38 M |
| Revenue (LFY) | 178.76 M | |
|---|---|---|
| Earnings (LFY) | -47.04 M | |
| Earnings (MRQ) | -13.97 M | |
| Next Earn Est | -0.354 | |
| Next Earnings | 08/03/2009 |
|
| EPS (TTM) | -0.77 | |
| 1yr EPS Growth | -0.39% |
| P/E Ratio (TTM) | — | |
|---|---|---|
| P/E Ratio (Fwd) | -12.00 | |
| PEG Ratio | -0.80 | |
| Return on Equity | -17.22 | |
| Beta | 0.42 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
Salix Pharmaceuticals is a finishing school for tummy drugs. Focusing on drugs for gastrointestinal diseases, the company shops for drug products that are nearing commercial viability. It then takes them ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | -0.354 8/3/09 | — — |
—
—
|
| Last Quarter | -0.372 3/31/09 | -0.29 3/31/09 |
0.082
Beat
|
| 2 Quarters Ago | -0.127 12/31/08 | -0.22 12/31/08 |
-0.093
Missed
|
| Quarterly - 03/31/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 44.77 M | 178.77 M |
| Gross Profit | 32.37 M | 125.06 M |
| Operating Income | -12.72 M | -46.66 M |
| Net Income | -13.97 M | -47.04 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts